BCRX
$7.79-2.87%
BioCryst Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.07%Nasdaq Composite 0.007%Russell 3000 0.004%US Stock Market 0.004%
BioCryst Pharmaceuticals Inc. monthly returns
BioCryst Pharmaceuticals Inc. has averaged 2.83% per month, positive in 51% of months. Month-by-month returns for BioCryst Pharmaceuticals Inc. (BCRX) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+2.8%
382 months
Best month
+183.9%
Jul 2013
Worst month
-71.4%
Feb 2016
Positive months
51%
of all months
BioCryst Pharmaceuticals Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -6.5% | |
| Sep 2026 | -14.1% | |
| Aug 2026 | +8.0% | |
| Jul 2026 | -10.2% | |
| Jun 2026 | +12.2% | |
| May 2026 | -2.7% | |
| Apr 2026 | -3.8% | |
| Mar 2026 | +8.8% | |
| Feb 2026 | +33.0% | |
| Jan 2026 | -15.6% | |
| Dec 2025 | +8.6% | |
| Nov 2025 | -1.9% | |
| Oct 2025 | -3.6% | |
| Sep 2025 | -8.7% | |
| Aug 2025 | +2.1% | |
| Jul 2025 | -9.2% | |
| Jun 2025 | -16.7% | |
| May 2025 | +21.5% | |
| Apr 2025 | +18.0% | |
| Mar 2025 | -12.9% | |
| Feb 2025 | +9.0% | |
| Jan 2025 | +5.1% | |
| Dec 2024 | +0.3% | |
| Nov 2024 | -6.4% | |
| Oct 2024 | +5.4% | |
| Sep 2024 | -12.5% | |
| Aug 2024 | +19.4% | |
| Jul 2024 | +17.8% | |
| Jun 2024 | -4.3% | |
| May 2024 | +56.4% | |
| Apr 2024 | -18.7% | |
| Mar 2024 | -9.8% | |
| Feb 2024 | +6.2% | |
| Jan 2024 | -11.5% | |
| Dec 2023 | +1.9% | |
| Nov 2023 | +7.1% | |
| Oct 2023 | -22.5% | |
| Sep 2023 | -0.4% | |
| Aug 2023 | -3.8% | |
| Jul 2023 | +5.0% | |
| Jun 2023 | -14.9% | |
| May 2023 | +8.7% | |
| Apr 2023 | -8.8% | |
| Mar 2023 | -5.8% | |
| Feb 2023 | -16.1% | |
| Jan 2023 | -8.1% | |
| Dec 2022 | -14.1% | |
| Nov 2022 | +0.1% | |
| Oct 2022 | +6.0% | |
| Sep 2022 | -9.4% | |
| Aug 2022 | +26.1% | |
| Jul 2022 | +4.2% | |
| Jun 2022 | +13.6% | |
| May 2022 | +0.2% | |
| Apr 2022 | -42.9% | |
| Mar 2022 | -2.1% | |
| Feb 2022 | +7.5% | |
| Jan 2022 | +11.6% | |
| Dec 2021 | +14.8% | |
| Nov 2021 | -19.2% | |
| Oct 2021 | +3.9% | |
| Sep 2021 | -9.7% | |
| Aug 2021 | -1.2% | |
| Jul 2021 | +2.0% | |
| Jun 2021 | +0.3% | |
| May 2021 | +35.5% | |
| Apr 2021 | +14.5% | |
| Mar 2021 | -5.7% | |
| Feb 2021 | +26.5% | |
| Jan 2021 | +14.4% | |
| Dec 2020 | +45.8% | |
| Nov 2020 | +33.8% | |
| Oct 2020 | +11.0% | |
| Sep 2020 | -17.1% | |
| Aug 2020 | +2.0% | |
| Jul 2020 | -14.5% | |
| Jun 2020 | +5.8% | |
| May 2020 | +15.1% | |
| Apr 2020 | +95.5% | |
| Mar 2020 | -33.3% | |
| Feb 2020 | +5.3% | |
| Jan 2020 | -17.4% | |
| Dec 2019 | +21.1% | |
| Nov 2019 | +42.5% | |
| Oct 2019 | -30.3% | |
| Sep 2019 | -4.0% | |
| Aug 2019 | -5.7% | |
| Jul 2019 | -16.4% | |
| Jun 2019 | +8.3% | |
| May 2019 | -52.9% | |
| Apr 2019 | -8.7% | |
| Mar 2019 | -1.5% | |
| Feb 2019 | -4.8% | |
| Jan 2019 | +7.6% | |
| Dec 2018 | -12.1% | |
| Nov 2018 | +25.4% | |
| Oct 2018 | -4.1% | |
| Sep 2018 | +6.6% | |
| Aug 2018 | +21.4% | |
| Jul 2018 | +3.0% | |
| Jun 2018 | -10.9% | |
| May 2018 | +30.7% | |
| Apr 2018 | +3.1% | |
| Mar 2018 | -4.0% | |
| Feb 2018 | +10.4% | |
| Jan 2018 | -8.4% | |
| Dec 2017 | -3.3% | |
| Nov 2017 | +12.9% | |
| Oct 2017 | -14.1% | |
| Sep 2017 | +2.7% | |
| Aug 2017 | -0.2% | |
| Jul 2017 | -8.1% | |
| Jun 2017 | +8.0% | |
| May 2017 | -18.8% | |
| Apr 2017 | -24.5% | |
| Mar 2017 | +34.6% | |
| Feb 2017 | -1.0% | |
| Jan 2017 | -0.5% | |
| Dec 2016 | +13.2% | |
| Nov 2016 | +38.0% |
Monthly total return (since Nov 2021)#
-40%-20%0%20%40%
Nov 2021-19%
Dec 2021+15%
Jan 2022+12%2022
Feb 2022+7.5%
Mar 2022-2.1%
Apr 2022-43%
May 2022+0.22%
Jun 2022+14%
Jul 2022+4.2%
Aug 2022+26%
Sep 2022-9.4%
Oct 2022+6.0%
Nov 2022+0.07%
Dec 2022-14%
Jan 2023-8.1%2023
Feb 2023-16%
Mar 2023-5.8%
Apr 2023-8.8%
May 2023+8.7%
Jun 2023-15%
Jul 2023+5.0%
Aug 2023-3.8%
Sep 2023-0.42%
Oct 2023-22%
Nov 2023+7.1%
Dec 2023+1.9%
Jan 2024-12%2024
Feb 2024+6.2%
Mar 2024-9.8%
Apr 2024-19%
May 2024+56%
Jun 2024-4.3%
Jul 2024+18%
Aug 2024+19%
Sep 2024-13%
Oct 2024+5.4%
Nov 2024-6.4%
Dec 2024+0.27%
Jan 2025+5.1%2025
Feb 2025+9.0%
Mar 2025-13%
Apr 2025+18%
May 2025+21%
Jun 2025-17%
Jul 2025-9.2%
Aug 2025+2.1%
Sep 2025-8.7%
Oct 2025-3.6%
Nov 2025-1.9%
Dec 2025+8.6%
Jan 2026-16%2026
Feb 2026+33%
Mar 2026+8.8%
Apr 2026-3.8%
May 2026-2.7%
Jun 2026+12%
Jul 2026-10%
Aug 2026+8.0%
Sep 2026-14%
Oct 2026-6.5%
BioCryst Pharmaceuticals Inc. returns by calendar month#
Every month of every year since 1995, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -6.48% — 20th of 32 Octobers since 1995 at the last close; the average October returned -5.0%.
| Month | −185%0+185% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +2.5% | +4.6% | 56% | +41.3% 2012 | -33.3% 2008 | |
| Feb | +0.1% | +0.2% | 53% | +33.5% 2012 | -71.4% 2016 | |
| Mar | +1.7% | -2.3% | 38% | +71.1% 2009 | -33.3% 2020 | |
| Apr | +4.7% | +1.8% | 53% | +95.5% 2020 | -42.9% 2022 | |
| May | +6.5% | +2.1% | 56% | +105.6% 2003 | -52.9% 2019 | |
| Jun | +3.3% | +6.9% | 63% | +70.6% 2001 | -71.1% 2002 | |
| Jul | +11.0% | +2.5% | 56% | +183.9% 2013 | -33.3% 2001 | |
| Aug | +10.8% | +2.1% | 63% | +125.6% 1999 | -24.8% 2015 | |
| Sep | -6.4% | -9.0% | 31% | +37.6% 2003 | -35.2% 2007 | |
| Oct | -5.0% | -3.6% | 48% | +41.5% 2005 | -56.2% 2000 | |
| Nov | +4.2% | +0.0% | 48% | +42.5% 2019 | -40.9% 2012 | |
| Dec | +0.8% | +0.3% | 52% | +45.8% 2020 | -20.3% 2009 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from BCRX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is BioCryst Pharmaceuticals Inc.'s average monthly return?
- BioCryst Pharmaceuticals Inc. (BCRX) has averaged about 2.83% per month, positive in roughly 51% of months. The best month was Jul 2013 (+183.9%) and the worst was Feb 2016 (-71.4%).
More on BioCryst Pharmaceuticals Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100